Projection: Implantable drug delivery market to reach $21.1B by 2018

Transparency Market Research predicts that the worldwide implantable drug delivery market will reach $21.1 billion by 2018. The market stood at $11.6 billion in 2011. Drivers of growth include cardiovascular diseases, diabetic retinopathy, colorectal cancer, chronic pain conditions, aging populations and unwanted pregnancies. In terms of specific devices, bioresorbable stents will propel the market's growth. And the Asia-Pacific region will see increased demand. Release